Study guide
15.3 Healthcare Infection Prevention and Environmental Transmission
Board Certified Infectious Diseases Pharmacist BCIDP
Track your progress as you read
Finished sections get a check mark.
1 Causes of Infectious Diseases
1.1 Bacterial Pathogens: Gram-Positive, Gram-Negative, and Atypical Organisms 1.2 Viral Pathogens: Respiratory, Herpesviruses, Hepatitis, and Emerging Viruses 1.3 Fungal Pathogens: Yeasts, Molds, and Dimorphic Fungi 1.4 Parasitic and Vector-Borne Pathogens: Protozoa and Helminths
2 Microbiology Diagnostics, Resistance & Host Response
2.1 Diagnostic Microbiology: Phenotypic, Molecular, and Rapid Diagnostic Methods 2.2 Molecular Mechanisms of Antimicrobial Resistance 2.3 Microbial Virulence Factors, Toxins, and Biofilm Dynamics 2.4 Host Immune Response to Infection and Immunopathology
3 Clinical Assessment & Diagnostic Evaluation
3.1 Clinical Assessment, Infection Screening, and Severity Stratification 3.2 Diagnostic Biomarkers and Clinical Laboratory Interpretation 3.3 Social Determinants of Health and Disparities in Infectious Diseases
4 Pharmacokinetics, Pharmacodynamics & Special Populations
4.1 Pharmacokinetic and Pharmacodynamic Optimization of Antimicrobials 4.2 Host and Environmental Risk Factors for Infection 4.3 Antimicrobial Dosing and Considerations in Special Populations
5 Respiratory and Skin/Soft Tissue Infections
5.1 Pharmacotherapy of Upper and Lower Respiratory Tract Infections 5.2 Pharmacotherapy of Skin and Soft Tissue Infections
6 Cardiovascular, Bone, and Joint Infections
6.1 Pharmacotherapy of Infective Endocarditis and CIED Infections 6.2 Pharmacotherapy of Osteomyelitis, Septic Arthritis, and PJI
7 Central Nervous System and Abdominal Infections
7.1 Pharmacotherapy of Central Nervous System Infections 7.2 Pharmacotherapy of Intra-abdominal, Hepatic, and GI Infections
8 Urologic, Gynecologic, and Sexually Transmitted Infections
8.1 Pharmacotherapy of Urinary Tract and Gynecologic Infections 8.2 Pharmacotherapy of Sexually Transmitted Infections
9 HIV Infection and Opportunistic Infections
9.1 Antiretroviral Therapy and Management of HIV-1 Infection 9.2 Prophylaxis and Management of HIV-Associated Opportunistic Infections
10 Infections in Immunocompromised Hosts and Complex Syndromes
10.1 Infections in Solid Organ Transplant and Hematologic Malignancy 10.2 Sepsis, Septic Shock, and Systemic Complications
11 Medication Administration and Adjunctive Therapies
11.1 Antimicrobial Administration, Vascular Access, and Stability 11.2 Adjunctive Pharmacotherapies and Supportive Care in Serious Infections 11.3 Assessment of Therapeutic Outcomes and Infection Failure
12 Therapeutic Drug Monitoring, Toxicity, and De-escalation
12.1 Therapeutic Drug Monitoring and Precision Pharmacokinetics 12.2 Antimicrobial Adverse Drug Events and High-Risk Drug Interactions 12.3 Antimicrobial De-escalation and IV-to-Oral Transition Strategies
13 Care Transitions, Patient Counseling & Travel Medicine
13.1 Outpatient Parenteral and Complex Oral Antimicrobial Therapy (OPAT/COPAT) 13.2 Patient and Caregiver Counseling, Education, and Adherence 13.3 Travel Medicine, Immunizations, and Prophylactic Regimens
14 Antimicrobial Stewardship Operations, Metrics & Resistance
14.1 Antimicrobial Stewardship Core Elements and Regulatory Mandates 14.2 Stewardship Metrics: Days of Therapy (DOT), DDD, and SAAR 14.3 Surveillance and Tracking of Antimicrobial Resistance Patterns 14.4 Cumulative Antibiogram Construction and CLSI M39 Analysis
15 Formulary Management, Infection Prevention & Population Health
15.1 Antimicrobial Formulary Management and Restriction Strategies 15.2 Public Health, Disease Reporting, and Adult Immunization Strategies 15.3 Healthcare Infection Prevention and Environmental Transmission
16 Literature Evaluation, Informatics & Quality Improvement
16.1 Infectious Diseases Information Resources, Databases, and Clinical Guidelines 16.2 Critical Literature Evaluation and Biostatistical Interpretation 16.3 Quality Improvement Methodologies and Medication Safety in ID 16.4 Clinical Informatics, Decision Support Systems, and Automated Alerts
15.3 Healthcare Infection Prevention and Environmental Transmission
Key Takeaways Explain This Topic AI
Transmission-based precautions build upon universal Standard Precautions, stratifying isolation requirements by transmission mode: Contact Precautions (gown and gloves upon room entry) for multidrug-resistant organisms; Enteric Contact Precautions (mandatory soap-and-water hand hygiene and sporicidal bleach disinfection) for C. difficile and norovirus; Droplet Precautions (surgical mask within 6 feet) for large-droplet pathogens; and Airborne Precautions (fit-tested N95/PAPR in an Airborne Infection Isolation Room with >= 12 air changes/hour) for M. tuberculosis, measles, and disseminated varicella-zoster.
Hand hygiene is the single most critical intervention for preventing healthcare-associated transmission: alcohol-based hand rub (ABHR, 60–95% alcohol) is the preferred standard for routine clinical interactions, but mechanical washing with soap and water is mandatory when hands are visibly soiled, after restroom use, and when caring for patients with spore-forming organisms (C. difficile) or non-enveloped enteric viruses, which resist alcohol denaturation.
Healthcare-associated infection prevention bundles dramatically reduce device-related bacteremia and morbidity: the CLABSI bundle emphasizes subclavian site selection, chlorhexidine-alcohol skin preparation with complete air-drying, maximal sterile barrier draping, and daily necessity review; the CAUTI bundle enforces strict insertion criteria, continuous closed drainage, and prompt removal.
The Ventilator-Associated Event (VAE/VAP) bundle targets aspiration prevention and ventilator weaning through 30–45 degree head-of-bed elevation, daily sedation interruption paired with spontaneous breathing trials, and subglottic secretion drainage, while the Surgical Site Infection (SSI) bundle requires weight-based perioperative antimicrobial prophylaxis within 60 minutes of incision, hair clipping rather than shaving, intraoperative normothermia, and perioperative glycemic control (<180 mg/dL).
The Spaulding classification system dictates medical device reprocessing: Critical items entering sterile tissue or blood require complete sterilization (steam, EtO, peracetic acid); Semi-critical items contacting mucous membranes require high-level disinfection (glutaraldehyde, OPA, hydrogen peroxide); and Non-critical items contacting intact skin require low-to-intermediate level disinfection, with sporicidal sodium hypochlorite (bleach) mandatory for C. difficile room turnover.
Last updated: October 2026
Healthcare Infection Prevention and Environmental Transmission
Hospital-acquired infections (HAIs)—including central line-associated bloodstream infections (CLABSIs), catheter-associated urinary tract infections (CAUTIs), ventilator-associated events (VAEs), surgical site infections (SSIs), and facility-acquired Clostridioides difficile —cause substantial morbidity, excess mortality, and significant financial penalties under national quality reporting programs. Preventing healthcare-associated transmission demands a rigorous understanding of microbial transmission dynamics, strict enforcement of Standard and Transmission-Based Precautions, implementation of evidence-based clinical care bundles, and systematic environmental decontamination.
Dynamics of Microbial Transmission in Healthcare Environments
Microorganisms transmit through acute care and ambulatory settings via well-defined physical mechanisms: MODES OF HEALTHCARE TRANSMISSION
- CONTACT TRANSMISSION DROPLET TRANSMISSION
- ┌───────────────────────────┐ ┌───────────────────────────┐
- │ Direct (body surface) or │ │ Large particles (> 5–10 μm)│
- │ Indirect (fomite/equipment)│ │ Ballistic flight ≤ 3–6 ft │
- │ MRSA, VRE, CRE, C. diff │ │ Influenza, N. meningitidis│
- └───────────────────────────┘ └───────────────────────────┘
- AIRBORNE TRANSMISSION ENVIRONMENTAL / WATERBORNE
- ┌───────────────────────────┐ ┌───────────────────────────┐
- │ Droplet nuclei (≤ 5 μm) │ │ Biofilms in plumbing, sink│
- │ Suspended in air currents │ │ traps, cooling towers │
- │ TB, Measles, Varicella │ │ Legionella, Pseudomonas │
- └───────────────────────────┘ └───────────────────────────┘
Contact Transmission:
Direct Contact: Physical transfer of microorganisms between an infected or colonized patient and a susceptible host (e.g., healthcare personnel hands during physical examination or patient repositioning).
Indirect Contact: Involves personal contact of a susceptible host with a contaminated inanimate intermediate object (fomite), such as shared stethoscopes, blood pressure cuffs, glucometers, bed rails, or unwashed computer keyboards.
Droplet Transmission:
Microorganisms propelled through the air in large respiratory droplets (> 5 to 10 μm) generated during coughing, sneezing, talking, or airway suctioning.
Droplets follow ballistic trajectories and travel only short distances through the air (typically ≤ 3 to 6 feet) before depositing onto the conjunctiva, nasal mucosa, or oral membranes of a susceptible host.
Does not remain suspended in the air; does not require specialized negative-pressure ventilation.
Airborne Transmission:
Microorganisms dispersed in microscopic droplet nuclei (≤ 5 μm) or evaporated respiratory residues that remain suspended in ambient air currents indefinitely.
Infectious particles travel long distances throughout rooms and ventilation ducts and are inhaled deeply into the terminal bronchioles and pulmonary alveoli.
Requires specialized environmental negative-pressure ventilation to prevent transmission.
Environmental and Waterborne Reservoirs:
Hospital water distribution systems and premise plumbing harbor complex biofilms supporting Legionella pneumophila , Pseudomonas aeruginosa , Stenotrophomonas maltophilia , and non-tuberculous mycobacteria (NTM).
Sink drain traps represent high-risk colonization reservoirs for carbapenemase-producing Enterobacterales ; aerators and turbulent water impact create infectious splashback aerosols contaminating nearby sterile supplies and patient care items.
Standard and Transmission-Based Precautions
Healthcare isolation practices are organized into two tiers: universal Standard Precautions applied to all patient encounters, and Transmission-Based Precautions applied based on documented or suspected pathogen transmission modes.
1. Standard Precautions: The Universal Baseline
Standard Precautions apply to all patients in all healthcare settings, regardless of suspected infection status:
Hand Hygiene: The cornerstone of infection control.
Alcohol-Based Hand Rub (ABHR): Solutions containing 60% to 95% ethanol or isopropanol represent the gold standard for routine hand decontamination before and after direct patient contact, after touching medical equipment, and before aseptic procedures. Alcohols rapidly denature microbial proteins and dissolve lipid bilayer membranes, achieving superior bactericidal efficacy in 15 to 20 seconds compared to soap and water.
The Sporicidal Exception (Soap and Water Mandate): Alcohols possess zero sporicidal activity . The complex, multilayered protein spore coat of bacterial endospores ( Clostridioides difficile ) and the rigid, non-enveloped protein capsid of enteric viruses ( Norovirus ) resist alcohol denaturation. When caring for patients with confirmed or suspected C. difficile or norovirus, when hands are visibly soiled with blood or proteinaceous material, or after using the restroom, personnel must perform mechanical hand washing with soap and water for at least 20 seconds . Soap and running water physically detach and flush spores off the skin surface.
Personal Protective Equipment (PPE): Donned based on anticipated exposure to blood, body fluids, secretions, excretions, non-intact skin, or mucous membranes (gloves, fluid-resistant gowns, surgical masks, eye protection).
Respiratory Hygiene / Cough Etiquette: Source control (masking symptomatic individuals), spatial separation (≥ 3 feet), and disposal of tissues.
Safe Injection Practices: "One needle, one syringe, only one time." Single-dose medication vials must never be accessed with a used syringe or needle, and multi-dose vials must be dedicated to a single patient whenever feasible.
2. Transmission-Based Precautions
Category PPE Requirements Room / Ventilation Specs Key Pathogen Indications
Contact Precautions Gown and gloves donned upon room entry; removed before exiting Private room preferred (or cohorting); dedicated equipment MRSA, VRE, CRE, A. baumannii , Scabies, extensive draining wounds
Enteric Contact Precautions Gown and gloves upon room entry; soap and water hand hygiene Private room; dedicated equipment; sporicidal bleach disinfection Clostridioides difficile , Norovirus, Rotavirus
Droplet Precautions Surgical / procedure mask donned upon entry; eye protection within 6 ft Private room; negative pressure NOT required; door may remain open Influenza, N. meningitidis (invasive), B. pertussis , Mumps, Rubella
Airborne Precautions Fit-tested N95 respirator or PAPR donned prior to room entry AIIR: Negative pressure, ≥ 12 ACH, door closed at all times M. tuberculosis (pulmonary), Measles (rubeola), Varicella-zoster (disseminated) AIRBORNE INFECTION ISOLATION ROOM (AIIR)
- ┌────────────────────────────────────────────────────────────────────────┐
- │ Air Inflow from Corridor ──► Door Remains CLOSED AT ALL TIMES │
- │ │
- │ Negative Pressure Differential: ≥ 2.5 Pascals (0.01 in H2O) │
- │ │
- │ Continuous Airflow Velocity: ≥ 12 Air Changes Per Hour (ACH) │
- │ │
- │ Exhaust Air ──► 100% Directly Exhausted Outdoors (Away from Inlets) │
- │ OR Filtered Through Certified HEPA Filter │
- └────────────────────────────────────────────────────────────────────────┘
Important
Airborne Isolation Room Mechanics: An Airborne Infection Isolation Room (AIIR) must maintain continuous negative air pressure relative to the surrounding hallway (≥ 2.5 Pa or 0.01 inch water gauge), verified daily using physical smoke tube tests or continuous electronic pressure monitors. The room must supply at least 12 air changes per hour (ACH) for new construction (≥ 6 ACH for existing facilities). Air must be exhausted directly outdoors or recirculated only through high-efficiency particulate air (HEPA) filtration. Healthcare personnel must don a fit-tested NIOSH-approved N95 respirator or powered air-purifying respirator (PAPR) before entering , and remove it only after exiting the room and closing the door.
Device-Associated and Surgical Infection Prevention Bundles
Clinical care bundles are structured groupings of evidence-based interventions that, when executed collectively and reliably, dramatically reduce device-associated HAIs.
1. Central Line-Associated Bloodstream Infection (CLABSI) Bundle
Insertion Bundle (Mandatory Sterile Practices):
Optimal Site Selection: Subclavian vein is preferred for non-tunneled central venous catheters (CVCs) in adults. The internal jugular vein is acceptable but carries higher oropharyngeal microbial colonization. The femoral vein is strictly avoided in adults due to heavy perineal bacterial contamination, high CLABSI rates, and deep vein thrombosis risk.
Skin Antisepsis: > 0.5% chlorhexidine gluconate (CHG) with 70% isopropyl alcohol applied with a vigorous back-and-forth friction scrub for ≥ 30 seconds and allowed to air dry completely (minimum 2 minutes). Do not wipe or blot dry.
Maximal Sterile Barrier (MSB) Precautions: The inserter must wear a sterile gown, sterile gloves, cap, and surgical mask with eye protection; the patient is covered head-to-toe with a large sterile full-body drape .
Ultrasound Guidance: Mandatory for internal jugular placement to minimize mechanical complications.
Maintenance Bundle:
Daily Necessity Review: Daily evaluation of line necessity with immediate removal of unneeded catheters.
Disinfection of Access Hubs: "Scrub the hub" for 10 to 15 seconds with chlorhexidine-alcohol or 70% alcohol pads prior to every line entry, allowing to air dry.
Dressing Integrity: Transparent semipermeable membrane dressings changed every 7 days (or every 48 hours for gauze dressings), or immediately if loose, soiled, or damp.
Daily CHG Bathing: Daily chlorhexidine skin cleansing in ICU patients aged ≥ 2 months reduces bloodstream seeding from skin flora.
2. Catheter-Associated Urinary Tract Infection (CAUTI) Bundle
Appropriate Clinical Indications for Indwelling Catheterization:
Acute urinary retention or bladder outlet obstruction.
Precise hourly urine volume measurement in critically ill, hemodynamically unstable patients.
Perioperative management for selected urologic/gynecologic surgeries or prolonged operative times.
Facilitation of healing in open stage III or IV pressure ulcers in the sacral or perineal region in incontinent patients.
Palliative end-of-life care.
Inappropriate Indications: Convenience of staff, routine urine output measurement in non-critical patients, or incontinence management without open sacral wounds.
Maintenance Essentials:
Maintain an uninterrupted closed drainage system .
Maintain downward gravity flow: Keep catheter tubing free of kinks and dependent loops; keep the collection bag below the level of the bladder at all times to prevent retrograde reflux of colonized urine into the bladder.
Secure the catheter to the patient's thigh to prevent urethral traction and trauma.
Routine catheter irrigation or routine surveillance urine cultures are contraindicated.
3. Ventilator-Associated Event (VAE / VAP) Bundle
Head-of-Bed Elevation: Maintain bed elevation at 30° to 45° continuously (unless medically contraindicated) to prevent passive gastroesophageal reflux and aspiration of gastric secretions.
Daily Sedation Interruption and Spontaneous Breathing Trials (SBT): Daily coordinated "sedation vacation" to assess readiness for extubation, shortening total ventilator days.
Subglottic Secretion Drainage (SSD): Use specialized endotracheal tubes equipped with a continuous or intermittent subglottic suction port to remove pooled oropharyngeal secretions above the cuff in patients expected to be intubated for > 48 to 72 hours.
Oral Care: Comprehensive oral hygiene, including mechanical toothbrushing and antiseptics.
Peptic Ulcer Disease (PUD) Prophylaxis and Deep Vein Thrombosis (DVT) Prophylaxis.
4. Surgical Site Infection (SSI) Prevention Bundle PERIOPERATIVE SSI PREVENTION TIMELINE
- Pre-Op (60 min pre-incision) Intra-Operative Post-Operative
- ┌────────────────────────────┐ ┌──────────────────────────────┐ ┌───────────────┐
- │ • Cefazolin IV infusion │ │ • Normothermia (≥ 35.5–36°C) │ │ • D/C Abx │
- │ (120m for Vanc / FQ) │ │ • Glycemic Control (< 180) │ │ strictly │
- │ • Hair clipping (NO RAZORS)│ │ • Redose Abx every 1–2 t1/2 │ │ ≤ 24 hours │
- │ • CHG-alcohol skin prep │ │ • Maintain tissue FiO2 │ │ post-op │
- └────────────────────────────┘ └──────────────────────────────┘ └───────────────┘
Perioperative Antimicrobial Prophylaxis Timing and Dosing:
Administer IV antibiotic prophylaxis within 60 minutes prior to surgical incision (extended to 120 minutes for vancomycin or fluoroquinolones to avoid infusion-related reactions).
Weight-based dosing: Cefazolin 2 g for patients < 120 kg; 3 g for patients ≥ 120 kg.
Intraoperative redosing: Redose antimicrobial if surgery exceeds 1 to 2 half-lives of the drug (e.g., redose cefazolin every 4 hours from initial dose), or with massive blood loss (> 1,500 mL).
Discontinuation: Stop prophylaxis within 24 hours postoperatively (or at wound closure). Prolonging antibiotics beyond 24 hours does not decrease SSI and induces antimicrobial resistance.
Hair Removal: If hair removal is necessary, use electric clippers immediately prior to surgery. Razors are strictly prohibited because razor shaving causes microscopic dermal lacerations that become colonized with bacteria, doubling SSI rates.
Normothermia: Maintain core body temperature ≥ 35.5°C to 36.0°C throughout surgery (hypothermia induces peripheral vasoconstriction, reduces tissue oxygen tension, and impairs neutrophil phagocytic killing).
Perioperative Glycemic Control: Maintain blood glucose < 180 mg/dL in all patients (diabetic and non-diabetic).
- Medical Device Reprocessing and Environmental Decontamination
- 1. The Spaulding Classification System
Formulated by Dr. Earle Spaulding, this framework dictates the necessary level of disinfection or sterilization based on the degree of infection risk associated with the device's clinical use. SPAULDING CLASSIFICATION PYRAMID
- ▲
- /│\
- / │ \
- / │ \
- / │ \
- / CRITICAL \
- / (Sterility) \
- /─────────────────\
- / SEMI-CRITICAL \
- / (High-Level Dis.) \
- /───────────────────────\
- / NON-CRITICAL \
- / (Low/Intermediate Disinf) \
- /─────────────────────────────\
Critical Items:
Tissue Contact: Instruments entering sterile body tissues, the vascular system, or sterile body cavities.
Examples: Surgical scalpels, forceps, implants, cardiac catheters, arthroscopes, laparoscopes, biopsy forceps passed through endoscopes.
Required Reprocessing: Sterilization (complete destruction of all microbial life, including all vegetative bacteria, mycobacteria, bacterial endospores, fungi, and viruses).
Methods: High-pressure saturated steam autoclaving (preferred), ethylene oxide (EtO) gas (for heat-sensitive items), vaporized hydrogen peroxide (VHP), peracetic acid immersion.
Semi-Critical Items:
Tissue Contact: Devices coming into contact with intact mucous membranes or non-intact skin, but not penetrating sterile tissue.
Examples: Flexible gastrointestinal endoscopes, bronchoscopes, transesophageal echocardiography (TEE) probes, endotracheal tubes, respiratory therapy equipment, vaginal/rectal ultrasound probes.
Required Reprocessing: High-Level Disinfection (HLD) (destroys all vegetative bacteria, mycobacteria, viruses, and fungi; may not kill all bacterial endospores).
Chemical Agents: Glutaraldehyde (≥ 2.0%), Ortho-phthalaldehyde (OPA 0.55%), Hydrogen peroxide (7.5%), Peracetic acid (0.2%). Requires strict validation of contact time, temperature, and chemical test strip verification of the Minimum Effective Concentration (MEC) prior to every cycle.
Non-Critical Items:
Tissue Contact: Items contacting only intact, healthy skin.
Examples: Bedpans, blood pressure cuffs, crutches, stethoscopes, bed rails, bedside tables, computer keyboards, IV poles.
Required Reprocessing: Low-to-Intermediate Level Disinfection (destroys vegetative bacteria, most fungi, and enveloped viruses; does not reliably kill mycobacteria or bacterial endospores).
Chemical Agents: Quaternary ammonium compounds, 70% to 90% isopropyl alcohol, phenolic compounds, accelerated hydrogen peroxide.
2. Sporicidal Environmental Cleaning for Clostridioides difficile
Clostridioides difficile endospores persist on dry hospital surfaces for months, resisting desiccation and common quaternary ammonium hospital disinfectants.
Sporicidal Disinfectant Standard: Terminal cleaning of rooms vacated by patients with C. difficile mandates an EPA-registered sporicidal disinfectant, most commonly sodium hypochlorite (dilute household bleach at a 1:10 dilution, yielding approximately 5,000 ppm available chlorine) .
Adjunctive No-Touch Technologies: Following manual physical cleaning, automated Ultraviolet-C (UV-C) light towers (emitting radiation at 254 nm to disrupt microbial DNA) or Vaporized Hydrogen Peroxide (VHP) systems can be deployed as secondary adjuncts to decontaminate shadowed surfaces and reduce residual spore loads.